Simplified synthesis of anti-oxidant small molecule OHPyN3 Authors: David Mingle, Nitish Kumar, Kayla N Green Published: 2026 ABSTRACT AbstractWe have designed a short, improved synthetic strategy for the synthesis of a multi-tactical anti-oxidant small macrocycle molecule. The overall simplified 6-step synthetic scheme gave a chemical yield of 45.7 % compared to the previously reported strategy of 22.4 %. The synthesis of the macrocycle started with esterification of chelidamic acid through a series of reactions, including Richman-Atkins macrocyclization, and ends with global deprotection of compound 6 to obtain the final product.Keywords: Oxidative stress, Anti-oxidant, Macrocycle, Richman-Atkins reaction, Reactive oxygen species Specifications table Subject areaChemistryMore specific subject areaSynthetic chemistryName of your methodImproved synthesis of anti-oxidant small molecule OHPyN3 using Richman Atkins reactionsName and reference of original methodLincoln, K. M.; Gonzalez, P.; Richardson, T. E.; Rutter, L.; Julovich, D. A.; Simpkins, J. W.; Green, K. N. A potent antioxidant small molecule aimed at targeting metal-based oxidative stress in neurodegenerative disorders. Chem. Commun. 2013, 49, 2712–2714Resource availabilityNone Background Oxidative stress is a substantial contributor to the development of many diseases (Fig. 1), including Alzheimer’s, Parkinson’s, cancer, heart disease, and many others. However, there is no widely adopted clinical approach to therapy [[1], [2], [3], [4]]. While Nature employs antioxidant small molecules to stoichiometrically scavenge radicals (direct reactivity, i.e. glutathione or Vitamin C), most antioxidant defense within cells is achieved through antioxidant enzyme pathways (catalytic, i.e. superoxide dismutase (SOD) and catalase (CAT)) [5,6]. This latter is controlled by the NRF2 (Nuclear factor erythroid 2-related factor 2) transcriptional pathway. Only recently have such pathways gained significant attention as a potential therapeutic target [[7], [8], [9]]. (Top) Reactive oxygen species leading to disease. (Bottom) Molecule 1 (OHPyN3). Our lab has reported a small molecule OHPyN3 (1, Fig. 1), a remarkable pyridinophane macrocycle with multi-tactical antioxidant reactivity: (1) Nrf2 activation; (2) radical scavenging; (3) metal-binding; and (4) mimics antioxidant enzymes (SOD and CAT) when bound to iron or copper ions [[10], [11], [12]]. The therapeutic potential of 1, isolated as the triply protonated salt, is being explored for treatments related to diseases of the central nervous system and eye, for example [[13], [14], [15], [16], [17]]. However, our original studies reported a lengthy and cumbersome approach to synthesis [17]. As a result, we report herein a streamlined approach using fewer steps, increased yield, and lowered cost. Method details. Method details. The original synthesis of 1 involved a seven-step process (Scheme 1) with an overall yield of 22.4 % and Cost of Academic Methodology (CAM) equivalent to $41,297.6/mol [18]. Given the commercial viability of this molecule and its derivatives, a new synthetic protocol was needed. A significant contributor to the total cost of synthesis was the use of Pd in the removal of the benzyl protecting group. Moreover, the use of thionyl chloride in the synthesis made work-ups arduous. As a result, a new synthetic scheme (Scheme 2) was designed that modified the protection strategies of chelidamic acid and the diethylene triamine. The following discussion provides a detailed description of each process, with an emphasis on overall yields, CAM, and processing time. Previously reported methods used to produce compound 1. New synthetic scheme. As with the majority of pyridine containing macrocycles, known as pyridinophanes, synthesis begins with a derivative of lutidine. In this case, esterification of chelidamic acid is used to furnish compound 2 in an absolute ethanol with thionyl chloride [17,19,20]. Longer reflux time, modified from 6 to 15 h, improved yield from 70 % to 90 %, producing a white solid. Our previous reports used a benzyl moiety to protect the primary alcohol of 2. While this strategy provided excellent yield (94 %), the ultimate need to remove this moiety using Pd/C proved to be cost-prohibitive for scale-up. The 3,4-Dihydro-2H-pyran (THP) group proved to be an excellent choice: (1) The conversion of aryl alcohols to O-THP is reported to be good to excellent [21], (2) THP tolerates Richman-Atkins basic cyclization conditions, and (3) THP can be removed congruently to removal of many N-atom protecting groups (acidic conditions). THP protection was carried out on compound 2 to protect the primary alcohol under reflux for 15 h, resulting yellow solid in excellent (95 %) yield and CAM of $3719.5/mol. THP is used preferentially here because of the exposure concerns related to benzyl bromide using our previous approach. Compound 3 was readily reduced to the corresponding diol using NaBH4 refluxing in an absolute ethanol (85 %, $817.2/mol). Moreover, this step uses half the volume of dichloromethane in the work-up compared to the original procedure. Our previous approach converted the alcohol groups of 8 to alkyl chlorides using thionyl chloride with excellent yield (95 %, $267.6/mol). However, we opted to modify our approach to use an OTs derivative for cyclization because (1) we can decrease the use of thionyl chloride in synthesis, which lowered safety concerns and simplified work-up procedures, (2) we found this step to scale up easily compared to conversion of alkyl halides, and (3) the cyclization yields of alkyl halides and OTs in Richman Atkins reactions are comparable. As a result, the primary diols in compound 4 were tosylated using KOH as base in a DCM/H2O mixture to yield our top synthon 5. (85 %, $1336.7/mol) based on similar procedures[22,23] (58–90 %) reported by others. Compound 5 was synthesized according to previously methods (85 %, $1336.7/mol) [15,17,23,24]. Various protecting strategies of the diethylene triamine synthon were explored for macrocyclization (Table 1). Richman-Atkins reactions for the synthesis of pyridinophanes are known to proceed with OTs derivatives of chelidamic acid, similar to 5, combined with base and diethylene triamine protected by bulky sulfonyl Ns and Ts moeities [22,25]. We explored 4-Ts (13), 2-Ts (14), 2-Ns (15). Initial attempts in anhydrous dimethylformamide using cesium carbonate resulted in poor yields when using 14 (10 %) and 15 (NR). Cyclization of compound 5 and compound 15 showed no reaction under Richman-Atkins conditions (DMF, CsCO3). However, the use of commercially available 4-Methyl-N,N-bis(2-(4-methylphenylsulfonamido ethyl)benzenesulfonamide 13 in DMF afforded compound 6, a white solid in 78 % yield and $598.92/mol. This yield is on the high end of cyclization reactions, with those reported varying from 57–83 % [15,26. Table 1Reaction yields for Richman-Atkins conditions (DMF, CsCO3) for the cyclization of 5 with the protected diethylene triamines (13–15).Table 1 dummy alt textImage, table 1 dummy alt textNR: No reaction, Macrocyclization of compound 5 and 14 showed no reaction. Reaction yields for Richman-Atkins conditions (DMF, CsCO3) for the cyclization of 5 with the protected diethylene triamines (13–15). NR: No reaction, Macrocyclization of compound 5 and 14 showed no reaction. Another advantage for the use of N-tosyl in compound 6 was that it enabled global deprotection with concentrated sulfuric acid in an acid-catalyzed reaction. This approved removed both N-Ts and THP to yield 1, as a white solid. The water-soluble product 1 is stable indefinitely. Cost analysis We carried out a Cost of Academic Methodology (CAM) analysis for the synthesis of compound 1 to understand the production cost of the synthesis. CAM ($/mol) is equal to the sum of all prices ($/mol) for the reagents and divided by the reaction yield [18]. The CAM for the new synthetic route was determined to be $7887.8/mol, which excludes labor and solvents used compared to the previous method of $41,297.6/mol. An estimated cost of less than $4/g is required for each gram of compound 1 produced, a reduction of the cost by 81 % from the original synthesis. Conclusion In this new scheme, we have simplified the synthesis of an anti-oxidant small molecule 1 with a high overall chemical yield of 45.7 %, representing a 23.3 % increase from previous yields (22.4 %) [17]. In a reduced number of steps, replacement of nosyl protected triamine to tosyl protected triamine enabled global deprotection of tosyl group and THP group in one step. The cost of producing a gram of compound 1 is significantly decreased by 81 %. Moreover, the overall time needed to complete the new synthetic scheme is roughly 6 working days, compared to the previously reported methods, which required roughly 2.5 weeks. Limitations None. Ethics statements None. CRediT author statement David Mingle: Investigation, Conceptualization, Methodology, Writing – review & editing. Kayla Green: Conceptualization, Methodology, Supervision, Writing – review & editing. Declaration of competing interest There are no conflicts of interest to declare. Acknowledgments The authors acknowledge generous support from the National Institutes of General Medical Sciences 2R15GM123463 and Welch Foundation P-2195–20240404 and X-d-0014–20250717. Footnotes Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.mex.2026.103950. Supplementary materials Data availability No data was used for the research described in the article. References Associated Data Supplementary Materials Data Availability Statement No data was used for the research described in the article.